Scientific innovation creates extraordinary opportunities, but it also creates uncertainty.
Whether evaluating a new technology, shaping an R&D strategy, or assessing scientific risk before investment, organisations need more than technical expertise. They need independent scientific judgement.
That is why I founded Darley Scientific Advisory.
I am Dr. Paula Darley. Throughout my career, I have worked at the intersection of scientific research, biotechnology R&D and innovation. I have seen first-hand how difficult it can be to make important decisions when the science is complex, the evidence is incomplete, or the path forward is uncertain.
My approach is grounded in asking the right scientific questions, examining the evidence objectively, and turning complex information into something decision-makers can use.
Every engagement begins with the same principles:
Independence before opinion.
Evidence before assumption.
Scientific rigour without unnecessary complexity.
Practical recommendations that can be acted on.
I believe good scientific advice should do more than demonstrate technical knowledge. It should help people understand what the evidence really tells them, where the uncertainties lie, and what those findings mean in practice.
My career has given me experience across biologics, vaccines, microbiology and protein sciences, as well as technology evaluation and biotechnology innovation.
I have also assessed biotechnology innovations and grant applications for European funding programmes, including at Horizon Europe / EIC programme level.
This combination of scientific depth and broader R&D and innovation experience allows me to look beyond the science itself and consider what the evidence means for the decision that needs to be made.
Good scientific advice should make difficult decisions clearer.
My role is to provide an independent perspective, identify the key scientific questions, and help decision-makers understand the opportunities, risks, and uncertainties before taking the next step.
If you have a scientific, technology or R&D challenge to discuss, I would be delighted to hear from you.